Recombinant Human Follistatin 288 (FS-288) Protein Summary
Product Specifications
The ED50 for this effect is 0.05‑0.25 μg/mL in the presence of 7.5 ng/mL of rhActivin A.
Gly30-Asn317, with an N-terminal Met
Analysis
Product Datasheets
Carrier Free
CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.
In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.
5836-FS
Formulation | Lyophilized from a 0.2 μm filtered solution in Acetonitrile and TFA with BSA as a carrier protein. |
Reconstitution | Reconstitute at 100 μg/mL in PBS containing at least 0.1% human or bovine serum albumin. |
Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. |
Stability & Storage: | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
5836-FS/CF
Formulation | Lyophilized from a 0.2 μm filtered solution in Acetonitrile and TFA. |
Reconstitution | Reconstitute at 100 μg/mL in PBS. |
Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. |
Stability & Storage: | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Reconstitution Calculator
Background: Follistatin
Follistatin 288 (FST288) is one of three forms of follistatin, a secreted glycoprotein that was first identified as a follicle-stimulating hormone inhibiting substance in ovarian follicular fluid (1, 2). Human follistatin 288 cDNA encodes a 317 amino acid (aa) protein with a 29 aa signal sequence, and a 288 aa mature region. Human FST288 shares 97 - 99% aa identity with corresponding regions of mouse, rat, equine, ovine, porcine and bovine FST. All forms of follistatin, including FST288, FST303 and FST315, contain an N-terminal atypical TGF binding domain and three follistatin domains (FS1 - 3) that contain EGF-like and kazal-like motifs. A highly acidic C-terminal tail is missing in the splice variant FST288, partially present in the proteolytically produced FST303, and full-length in the most abundant form, FST315 (5, 8, 9). FSTs inhibit activins by surrounding activin dimers. FST288 shows the highest affinity for activins due to its extended configuration, while FST315 is in a folded form (2, 8). Expression of the isoforms is restricted such that FST288, which has higher affinity for heparin-sulfated proteoglycans when unbound, is present in tissues while FST315 is the sole form in plasma and ovarian follicular fluid (5, 8, 9). In addition to activin, follistatins regulate the bioavailability of other members of the TGF-beta superfamily, such as BMP6, BMP7 and myostatin (5). Follistatins also regulate hematopoietic stem cell adhesion to fibronectin via FS2, and bind angiogenin via FS2 and FS3 (6, 7). Genetic deletion of follistatin in mice, or expression of only the FST288 form, is perinatally lethal due to defects of lung, skin and musculoskeletal system (10). Mice that express only the FST315 isoform survive, but exhibit defects in vascularization and female fertility (10).
- Shimasaki, S. et al. (1988) Proc. Natl. Acad. Sci. USA 85:4218.
- Thompson, T.B. et al. (2005) Dev. Cell 9:535.
- Sidis, Y. et al. (2005) Endocrinology 146:130.
- Keutmann, H.T. et al. (2004) Mol. Endocrinol. 18:228.
- Sidis, Y. et al. (2006) Endocrinology 147:3586.
- Maguer-Satta, V. et al. (2006) Exp. Cell Res. 312:434.
- Gao, X. et al. (2007) FEBS Lett. 581:5505.
- Lerch, T.F. et al. (2007) J. Biol. Chem. 282:15930.
- Schneyer, A.L. et al. (2004) J. Clin. Endocrinol. Metab. 89:5067.
- Lin, S-Y. et al. (2008) Mol. Endocrinol. 22:415.
Citations for Recombinant Human Follistatin 288 (FS-288) Protein
R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.
10
Citations: Showing 1 - 10
Filter your results:
Filter by:
-
Activin A Limits VEGF-Induced Permeability via VE-PTP
Authors: Baccouche, B;Lietuvninkas, L;Kazlauskas, A;
International journal of molecular sciences
Species: Human
Sample Types: Whole Cells
Applications: Bioassay -
Follistatin Is a Novel Chemoattractant for Migration and Invasion of Placental Trophoblasts of Mice
Authors: J Li, Y Qi, K Yang, L Zhu, X Cui, Z Liu
Cells, 2022-11-29;11(23):.
Species: Mouse
Sample Types: Whole Cells
Applications: Cell Culture -
Role of stromal activin A in human pancreatic cancer and metastasis in mice
Authors: G Mancinelli, C Torres, N Krett, J Bauer, K Castellano, R McKinney, D Dawson, G Guzman, R Hwang, S Grimaldo, P Grippo, B Jung
Scientific Reports, 2021-04-12;11(1):7986.
Species: Human
Sample Types: Protein
Applications: Reference Standard -
Increased stiffness of the tumor microenvironment in colon cancer stimulates cancer associated fibroblast-mediated prometastatic activin A signaling
Authors: J Bauer, MAB Emon, JJ Staudacher, AL Thomas, J Zessner-Sp, G Mancinelli, N Krett, MT Saif, B Jung
Sci Rep, 2020-01-09;10(1):50.
Species: Human
Sample Types: cell culture
Applications: Cell Culture -
Activin in acute pancreatitis: Potential risk-stratifying marker and novel therapeutic target.
Authors: Jonas J Staudacher, Cemal Yazici, Timothy Carroll, Jessica Bauer, Jingbo Pang, Nancy Krett, Yinglin Xia, Annette Wilson, Georgios Papachris, Andrea Dirmeier, Claudia Kunst, David C Whitcomb, Giamila Fantuzzi, Barbara Jung
Scientific Reports, 2017-10-06;0(0):2045-2322.
Species: Mouse
Sample Types: In Vivo
Applications: In Vivo -
Activin signaling is an essential component of the TGF-? induced pro-metastatic phenotype in colorectal cancer
Authors: JJ Staudacher, J Bauer, A Jana, J Tian, T Carroll, G Mancinelli, Ö Özden, N Krett, G Guzman, D Kerr, P Grippo, B Jung
Sci Rep, 2017-07-17;7(1):5569.
Species: Human
Sample Types: Whole Cells
Applications: Bioassay -
Structural basis for potency differences between GDF8 and GDF11
Authors: RG Walker, M Czepnik, EJ Goebel, JC McCoy, A Vujic, M Cho, J Oh, S Aykul, KL Walton, G Schang, DJ Bernard, AP Hinck, CA Harrison, E Martinez-H, AJ Wagers, RT Lee, TB Thompson
BMC Biol, 2017-03-03;15(1):19.
Species: Human
Sample Types: Whole Cells
Applications: Bioassay -
Patient-specific hepatocyte-like cells derived from induced pluripotent stem cells model pazopanib-mediated hepatotoxicity
Authors: Y Choudhury, YC Toh, J Xing, Y Qu, J Poh, L Huan, HS Tan, R Kanesvaran, H Yu, MH Tan
Sci Rep, 2017-01-25;7(0):41238.
Species: Human
Sample Types: Whole Cells
Applications: Bioassay -
Follistatin in chondrocytes: the link between TRPV4 channelopathies and skeletal malformations.
Authors: Leddy H, McNulty A, Lee S, Rothfusz N, Gloss B, Kirby M, Hutson M, Cohn D, Guilak F, Liedtke W
FASEB J, 2014-02-27;28(6):2525-37.
Species: Chicken
Sample Types: Whole Tissue
Applications: Bioassay -
The role of the activin system in keloid pathogenesis.
Authors: Mukhopadhyay A, Chan SY, Lim IJ, Phillips DJ, Phan TT
Am. J. Physiol., Cell Physiol., 2006-09-13;292(4):C1331-8.
Species: Human
Sample Types: Whole Cells
Applications: Bioassay
FAQs
No product specific FAQs exist for this product, however you may
View all Proteins and Enzyme FAQsReviews for Recombinant Human Follistatin 288 (FS-288) Protein
There are currently no reviews for this product. Be the first to review Recombinant Human Follistatin 288 (FS-288) Protein and earn rewards!
Have you used Recombinant Human Follistatin 288 (FS-288) Protein?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image